Tuesday, February 4, 2020

Toronto-based BenchSci, which is using AI to accelerate drug discovery research and reduce related costs, raises $22M Series B led by F-Prime Capital (Kyle Wiggers/VentureBeat)

Kyle Wiggers / VentureBeat:
Toronto-based BenchSci, which is using AI to accelerate drug discovery research and reduce related costs, raises $22M Series B led by F-Prime Capital  —  Assessing the health of pharmaceutical R&D by unearthing hidden patterns in procurement data is a task made simpler by AI.



at
Labels:

No comments:

Post a Comment

Subscribe to: Post Comments (Atom)

Finland, Canada, the US, and other countries are testing tech for passport-free travel, including facial recognition and a "digital travel credential" (Matt Burgess/Wired)

Matt Burgess / Wired : Finland, Canada, the US, and other countries are testing tech for passport-free travel, including facial recogniti...